Validation of the French Translation of the Scale HSCL25 in the Diagnosis of Depression in Primary Care
NCT ID: NCT02414711
Last Updated: 2025-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1128 participants
INTERVENTIONAL
2015-06-30
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telemedicine for Depression in Primary Care
NCT01701791
Paramedical Tele-education on Moderate Depressive Episodes
NCT06014125
Depression and Increased Health Services Utilization Among Elderly Primary Care Patients
NCT00279526
Treatment for Depression in the Primary Care Setting
NCT00055328
Prevalence of Anxiety Symptoms Among French General Practitioners
NCT06774092
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No depressed
If the result of the HSCL25 scale is inferior than 1.75, then the patient is considered as no depressed.
50 of these patients have to have a psychological interview with the PSE9 questionary to validate the result of the HSCL25 scale.
HSCL25 scale
The patient must answer to 25 questions of the HSCL25 scale. In function of the results, the patients was diagnosed depressed (≥1.75) or not depressed (\<1.75)
PSE9 questionary
On the 900 patients recruited, 50 patients who was diagnosed depressed or no depressed have to have a psychological interview with the PSE9 questionary to validate the first diagnosis done by the HSCL25 scale
Depressed
If the result of the HSCL25 scale is superior or equal to 1.75, then the patient is considered as depressed.
50 of these patients have to have a psychological interview with the PSE9 questionary to validate the result of the HSCL25 scale.
HSCL25 scale
The patient must answer to 25 questions of the HSCL25 scale. In function of the results, the patients was diagnosed depressed (≥1.75) or not depressed (\<1.75)
PSE9 questionary
On the 900 patients recruited, 50 patients who was diagnosed depressed or no depressed have to have a psychological interview with the PSE9 questionary to validate the first diagnosis done by the HSCL25 scale
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HSCL25 scale
The patient must answer to 25 questions of the HSCL25 scale. In function of the results, the patients was diagnosed depressed (≥1.75) or not depressed (\<1.75)
PSE9 questionary
On the 900 patients recruited, 50 patients who was diagnosed depressed or no depressed have to have a psychological interview with the PSE9 questionary to validate the first diagnosis done by the HSCL25 scale
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Women with a declared pregnancy to prevent puerperal depression whose support is different.
* Adult consultant to obtain a medical certificate
* Psychotic patients and\\or requiring immediate care
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrice NABBE, GP
Role: PRINCIPAL_INVESTIGATOR
GP department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cabinet médical en zone urbaine
Brest, France, France
Cabinet médical en zone rurale - Pôle Santé Universitaire
Lanmeur, France, France
Cabinet médical en zone semi-rurale
Plounéour-Trez, France, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nabbe P, Le Reste JY, Guillou-Landreat M, Gatineau F, Le Floch B, Montier T, Van Marwijk H, Van Royen P. The French version of the HSCL-25 has now been validated for use in primary care. PLoS One. 2019 Apr 4;14(4):e0214804. doi: 10.1371/journal.pone.0214804. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSCL25 Validation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.